Skip to main
KLTO
KLTO logo

Klotho Neurosciences Inc (KLTO)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy KLTO Stock

About Klotho Neurosciences Inc (KLTO)

Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Omaha, NE.
Market cap$29.77M
Today's volume2.09M
Revenue (TTM)
Avg. daily volume32.77M
EBITDA (TTM)-$8.2M
Open$0.47
Price / earnings ratio-1.07x
Today's range$0.45 - $0.52
Debt / equity
52 week range$0.11 - $3.91
5 year debt / equity
Beta (LTM)1.35x
Interest coverage-15.54x
Dividend & yield$0.00 (0.00%)
Current ratio135.74x
Ex-dividend date
Next earningsNov 18, 2025
Dividend payable date

Frequently Asked Questions (FAQ)

As of Sep 07, 2025, the market cap for KLTO stock is $29.78M

The current P/E ratio for KLTO stock is -1.07

The 52-week high for KLTO stock is $3.91. The current KLTO stock price $undefined is 100.00% below its 52-week high

The 52-week low for KLTO stock is $0.11. The current KLTO stock price $undefined has increased 100.00% from its 52-week low

No, the KLTO stock does not pay dividends to its shareholders

How to buy KLTO stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in KLTO stock

    Navigate to the Explore page. Then, type KLTO into the search bar. When you see KLTO stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased KLTO stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Klotho Neurosciences Inc Stock Earnings

The value each KLTO share was expected to gain vs. the value that each KLTO share actually gained.

KLTO (KLTO) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, KLTO's earnings per share (EPS) was $0. KLTO is expected to release next earnings on 11/18/2025, with an earnings per share (EPS) estimate of $0.

Buy KLTO Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.